author-photo

Anna Robinson

Aventis Pharma

3

Papers

17

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

REAL3: A multicenter randomized phase II/III trial of epirubicin, oxaliplatin, and capecitabine (EOC) versus modified (m) EOC plus panitumumab (P) in advanced oesophagogastric (OG) cancer—Response rate (RR), toxicity, and molecular analysis from phase II.

2011 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (11)
On-Bead and Solution Screening Approaches for Genomically Derived Targets

2002 Methods of Molecular Biology
Show All
- Source
- Cite
- Save
Citations (1)
Efficient discovery of inhibitory ligands for diverse targets from a small combinatorial chemical library of chimeric molecules

1999 Biochemical and Biophysical Research Communications
Show All
- Source
- Cite
- Save
Citations (5)